Cargando…
Do SGLT2 Inhibitors Improve Cardio-Renal Outcomes in Patients With Type II Diabetes Mellitus: A Systematic Review
Diabetes mellitus (DM) is associated with dreadful changes in the cardiovascular and renal systems, causing increased morbidity and mortality. Sodium-glucose cotransport-2 (SGLT2) inhibitors belong to the oral hypoglycemic group of drugs believed to reduce these events by various mechanisms in DM. W...
Autores principales: | Kalluri, Sahithi Reddy, Bhutta, Tinaz H, Hannoodee, Hanan, Al Khalili, Mahmoud, Theik, Nyein Wint Yee, Raji, Oluwatimilehin E, Shenwai, Priya, Shah, Rutul, Khan, Safeera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489544/ https://www.ncbi.nlm.nih.gov/pubmed/34650848 http://dx.doi.org/10.7759/cureus.17668 |
Ejemplares similares
-
The Outcomes of Acute Coronary Syndrome in Patients Suffering From Schizophrenia: A Systematic Review
por: Hannoodee, Hanan, et al.
Publicado: (2021) -
Relationship and Effects of Vitamin D on Metabolic Syndrome: A Systematic Review
por: Theik, Nyein Wint Yee, et al.
Publicado: (2021) -
Cardiovascular Benefit of Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Type 2 Diabetes: A Systematic Review
por: Georgiou, Petros, et al.
Publicado: (2021) -
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and Genital Infections in Patients With Diabetic Mellitus and Concomitant Coronary Artery Disease: A Single-Center Experience
por: Shah, Bhupesh R, et al.
Publicado: (2022) -
A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
por: Rao, Shiavax J, et al.
Publicado: (2022)